Company / Operating Cash Flow per Share
Upstream Bio, Inc. Operating Cash Flow per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.49
FY2025
5-year range
-$12.84 / -$2.49
FY2023-FY2025
Trend
+80.4%
vs FY2024
Sector context
#158 of 212
Health Care
What the data says
Upstream Bio, Inc.'s operating cash flow per share of $-2.49 is lower than 75% of companies in the Health Care sector (FY2025). Improved from $-12.84 to $-2.49 over the past 2 years.
Based on SEC 10-K filings.
-2.49 in FY2025.
Improved from $-12.84 to $-2.49 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 212This company -$2.49 Sector average -$14.72
▼
+83.1% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 80.4% year-over-year.
- Ranks #158 out of 212 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.68 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.49 | +80.4% |
| FY2024 | -$12.67 | +1.3% |
| FY2023 | -$12.84 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026